Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Vomiting 1Postoperative Nausea and Vomiting 1Nausea 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myeloid, Acute 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 21Cyclosporine 14fludarabine phosphate 13Whole-Body Irradiation 13Peripheral Blood Stem Cell Transplantation 13Filgrastim 10Rituximab 9Mycophenolic Acid 9Antilymphocyte Serum 9Radiotherapy 7Methotrexate 7Busulfan 7Melphalan 6Psychiatric Rehabilitation 5Etoposide 5Dexamethasone 5Cytarabine 5Aprepitant 5fludarabine 4Vincristine 4Ondansetron 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Cord Blood Stem Cell Transplantation 4plerixafor 3Zidovudine 3Therapeutics 3Stem Cell Transplantation 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Non-Hodgkin × Antiemetics × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡